Arjun Raghavan
Articles
Redefining Renal Cell Carcinoma: A Molecular Perspective on Classification and Clinical Implications
Dec 14, 2023 |
emjreviews.com | Arjun Raghavan |Rady Faculty |Ian Gibson |Robert Wightman
1. This article summarises the key pathologic and clinical characteristics of the molecularly-defined renal cell carcinoma (RCC) subtypes incorporated within the new 2022 World Health Organization (WHO) classification system. This change signifies a broader trend in oncology, emphasising the role of molecular and genomic tumour descriptions. 2. Molecularly-defined RCC subtypes may pose diagnostic challenges, due to morphological variability.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →